Diasome

Developing Smarter Insulin to Treat Diabetes with Robert Geho

February 28, 2019

Interview

Latest Updates

News

Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions

Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes

Could Aiming Insulin at the Liver Be an Answer to Using Less?